[1] DURABLE SUSTAINED VIROLOGICAL RESPONSE AFTER TREATMENT WITH PEGINTERFERON α-2a (PEGASYS®) ALONE OR IN COMBINATION WITH RlBAVlRlN (COPEGUS®): 5-YEAR FOLLOW-UP AND THE CRITERIA OF A CURE | Publicación